Oncolytics Biotech (ONC) Posts Quarterly Earnings, Beats Estimates By $0.02 EPS
Oncolytics Biotech (TSE:ONC) posted its quarterly earnings results on Thursday. The company reported ($0.05) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.07) by $0.02, Stock Ratings Network.com reports. During the same quarter in the prior year, the company posted ($0.06) earnings per share.
Oncolytics Biotech (TSE:ONC) remained flat at $1.45 during during mid-day trading trading on Thursday. The stock had a trading volume of 400 shares. Oncolytics Biotech has a 1-year low of $1.30 and a 1-year high of $3.62. The stock has a 50-day moving average of $1.51 and a 200-day moving average of $1.67. The company’s market cap is $125.5 million.
Oncolytics Biotech Inc (TSE:ONC) is a development-stage company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.